- Home
- CNSP vs SNES Comparison
CNSP vs SNES Comparison
Compare CNSP & SNES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNSP
- SNES
- Stock Information
- Founded
- CNSP 2017
- SNES 2004
- Country
- CNSP United States
- SNES United States
- Employees
- CNSP N/A
- SNES N/A
- Industry
- CNSP Biotechnology: Pharmaceutical Preparations
- SNES Agricultural Chemicals
- Sector
- CNSP Health Care
- SNES Industrials
- Exchange
- CNSP Nasdaq
- SNES Nasdaq
- Market Cap
- CNSP 5.4M
- SNES 1.6M
- IPO Year
- CNSP 2019
- SNES 2016
- Fundamental
- Price
- CNSP $0.12
- SNES $2.94
- Analyst Decision
- CNSP Strong Buy
- SNES Strong Buy
- Analyst Count
- CNSP 1
- SNES 1
- Target Price
- CNSP $0.50
- SNES $35.00
- AVG Volume (30 Days)
- CNSP 1.1M
- SNES 58.1K
- Earning Date
- CNSP 11-12-2024
- SNES 11-07-2024
- Dividend Yield
- CNSP N/A
- SNES N/A
- EPS Growth
- CNSP N/A
- SNES N/A
- EPS
- CNSP N/A
- SNES N/A
- Revenue
- CNSP N/A
- SNES $1,529,000.00
- Revenue This Year
- CNSP N/A
- SNES $91.45
- Revenue Next Year
- CNSP N/A
- SNES $101.31
- P/E Ratio
- CNSP N/A
- SNES N/A
- Revenue Growth
- CNSP N/A
- SNES 40.92
- 52 Week Low
- CNSP $0.10
- SNES $1.90
- 52 Week High
- CNSP $137.50
- SNES $48.60
- Technical
- Relative Strength Index (RSI)
- CNSP 30.55
- SNES 57.45
- Support Level
- CNSP $0.12
- SNES $2.18
- Resistance Level
- CNSP $0.14
- SNES $2.36
- Average True Range (ATR)
- CNSP 0.01
- SNES 0.26
- MACD
- CNSP 0.01
- SNES 0.09
- Stochastic Oscillator
- CNSP 30.63
- SNES 86.80
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.
About SNES SenesTech Inc.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.